GTR 105974825
Bids Are Invited For Price Registration For The Installment Purchase Of Medicines And Hospital Materials, To Meet The Demand Of The Municipalities Associated With Cisa, And Also For Use In Services Provided At Cisa, According To The Specifications Contained In The Term Of Reference That Forms Part Of This Notice As Annex I. The Company That Presents The Lowest Price Per Item Will Be Declared The Winner Of The Competition.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
105974825
Tendering Authority
Subscribe to view
Tender No
7/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Price Registration For The Installment Purchase Of Medicines And Hospital Materials, To Meet The Demand Of The Municipalities Associated With Cisa, And Also For Use In Services Provided At Cisa, According To The Specifications Contained In The Term Of Reference That Forms Part Of This Notice As Annex I. The Company That Presents The Lowest Price Per Item Will Be Declared The Winner Of The Competition.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
11-12-2025
Closed
Work Detail
Acebrophylline, Concentration: 10 Mg/Ml, Pharmaceutical Form: Syrup, 120 Ml Adult -, Concentration: 5 Mg/Ml, 120 Ml Children -, Acetylcysteine, Dosage: 200 Mg, Indication: Powder For Oral Solution - Envelope, Acetylcysteine, Dosage: 600Mg, Indication: Powder For Oral Solution, Acyclovir, Dosage:200 Mg -, 08/12/2025 - 10:04:38, 08/12/2025 - 10:05:07, Dosage:50 Mg/G, Usage:Cream, 10 G -, Acetylsalicylic Acid, Dosage:100 Mg -, Ascorbic Acid, Dosage: 100 Mg/Ml, Type Of Use: Injectable, 5 Ml, Folic Acid, Dosage:5 Mg -, Tranexamic Acid, Dosage:50 Mg/Ml, Pharmaceutical Form:Injectable Solution, Valproic Acid, Dosage:250 Mg -, Adenosine, Dosage:3 Mg/Ml, Injectable Solution, 2 Ml, Distilled Water For Autoclave - 5 Liters, Distilled Water, Physical Aspect: Sterile And Pyrogenic, 10 Ml -, 5 Ml -, Albendazole, Dosage: 40 Mg/Ml, Use: Oral Suspension, Dosage: 400 Mg -, Ethyl Alcohol, Alcohol Content: 70% (70°Gl), Type: Hydrated, Presentation: Liquid - 1 Liter, Alendronate Sodium, Dosage:70 Mg -, Alogliptin, Composition:Associated With Pioglitazone, Concentration:25 Mg + 30 Mg -, Concentration:25 Mg - Comp, Allopurinol, Dosage:300 Mg -, Alprazolam, Dosage:1 Mg -, Ambroxol, Composition:Hydrochloride Salt, Concentration:3 Mg/Ml, Form Pharmaceutical:Syrup, 120 Ml, Pediatric -, Concentration:6 Mg/Ml, Adult -, Amikacin Sulfate, Dosage:250 Mg/Ml, Indication:Injectable Solution, 2 Ml -, Aminophylline, Dosage:24 Mg/Ml, Amiodarone (Hydrochloride), Dosage:100Mg -, Dosage:50Mg/Ml, Indication:Injectable, 3 Ml -, Amitriptyline Hydrochloride, 25 Mg -, 75 Mg -, Amoxicillin, Active Ingredient:Associated With Potassium Clavulanate, Concentration:500Mg + 125Mg -, Concentration:500Mg -, Concentration:50Mg/Ml, Presentation:Powder For Oral Suspension, 150 Ml -, Active Ingredient Associated With Potassium Clavulanate, Convention 50 Mg/Ml + 12.5/Ml, Pharmaceutical Form Oral Suspension, 75 Ml -, Ampicillin (Sodium), Dosage: 1 G, Type Of Use: Injectable -, Amlodipine Besylate, Apixaban, Concentration:2.5 Mg -, Concentration:5 Mg -, Aripiprazole, Concentration:10 Mg -, Concentration:15 Mg -, Atenolol, Dosage:50 Mg -, Atorvastatin Calcium, Dosage:10 Mg -, Dosage:20 Mg -, Atropine Sulfate, Dosage:0.25 Mg/Ml, Usage:Solution Injectable, 1 Ml -, 50 Mg/Ml, Azithromycin (Dihydrate) Dosage:40Mg/Ml Presentation:Oral Suspension, 15 Ml, Azithromycin, Dosage:500 Mg -, Baclofen, 10 Mg -, Beclomethasone Dipropionate, Dosage:200 Mcg, Additional Features:Inhalation Capsules, With Inhaler, 200 Doses -, Benzylpenicillin, Presentation:Benzatine, Dosage:1,200,000Ui, Use:Injectable -, Dosage:600,000Ui, Presentation:Potassic, Composition:Associated With Procained Penicillin, Dosage:100,000Ui + 300,000Ui, Use:Injectable, , Betahistine Dihydrochloride, 16 Mg -, Concentration: 24 Mg -, Betamethasone, Composition: Acetate, Presentation: Associated With Betamethasone Phosphate, Dosage: 3Mg + 3Mg/Ml, Composition: Dipropionate, Dosage: 5Mg + 2Mg, Associated With Ketoconazole And Neomycin, Concentration: 0.5 Mg/G + 20 Mg/G + 1.5 Mg/G, Pharmaceutical Form: Ointment 30G, Composition: Phosphate, Dosage:4 Mg/Ml, Sodium Bicarbonate, 8.4%, Bimatoprost 0.3 Mg/Ml Timolol Maleate 6.8 G/Ml – Sterile Ophthalmic Solution 3 Ml, Biperiden, Dosage:2 Mg -, Bromazepam, Dosage:3 Mg -, Dosage:6 Mg -, Bromhexine Hydrochloride, Dosage 1, 6 Mg/Ml, Indication Syrup, 120 Ml -, Bromopride, Dosage:10 Mg, Presentation:Drops, 20 Ml Drops -, Dosage:5 Mg/Ml, Presentation:Injectable, Budesonide, Presentation:Nasal Aerosol, Concentration:32Mcg/Dose, Additional Features:Co Bottle
Key Value
Tender Value
8,936,303 - BRL
Tender Documents
Global Tender Document
28510aac-9975-46aa-b132-293774c9f85d.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.